To gauge the proteins identified as potential biomarkers to identify patients with atherosclerotic-rooted conditions (CAD/AVS), we compared the urinary levels of TIMP1, MMP2 and vWF in an independent population comprising 29 individuals: 19 CAD/AVS patients and 10 controls (Table 1—Testing cohort). Here, MMP2 is linked to coronary artery disorder.